Dąbek B. Apalutamide as a new option for postponing metastatic disease in hormone-resistant patients with biochemical recurrence in prostate cancer. OncoReview [Internet]. 2023Apr.1 [cited 2024Nov.22];13(1(49):24-6. Available from: https://journalsmededu.pl/index.php/OncoReview/article/view/2790